| Q58776119 | A comprehensive investigation using meta-analysis and bioinformatics on miR-34a-5p expression and its potential role in head and neck squamous cell carcinoma |
| Q33952171 | A comprehensive survey of miRNA repertoire and 3' addition events in the placentas of patients with pre-eclampsia from high-throughput sequencing |
| Q42180657 | A functional variant at miR-520a binding site in PIK3CA alters susceptibility to colorectal cancer in a Chinese Han population |
| Q35479084 | A functional variant at the miR-184 binding site in TNFAIP2 and risk of squamous cell carcinoma of the head and neck |
| Q36710893 | A functional variant at the miR-885-5p binding site of CASP3 confers risk of both index and second primary malignancies in patients with head and neck cancer |
| Q45060313 | A genetic variant in pre-miR-27a is associated with a reduced cervical cancer risk in southern Chinese women |
| Q50932878 | A highly specific and sensitive electroanalytical strategy for microRNAs based on amplified silver deposition by the synergic TiO2 photocatalysis and guanine photoreduction using charge-neutral probes. |
| Q57484422 | A novel gene-pair signature for relapse-free survival prediction in colon cancer |
| Q50854439 | A novel method of predicting microRNA-disease associations based on microRNA, disease, gene and environment factor networks. |
| Q49607836 | A robust gene signature for the prediction of early relapse in stage I-III colon cancer |
| Q84943840 | Aberrant microRNA expression and its implications in the pathogenesis of leukemias |
| Q34706019 | Adenoid cystic carcinoma of breast: Recent advances |
| Q37328429 | Alterations of MicroRNAs in Solid Cancers and Their Prognostic Value |
| Q21202158 | An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma |
| Q35171752 | An integrative meta-analysis of microRNAs in hepatocellular carcinoma. |
| Q35970795 | Applications of MicroRNAs in the Diagnosis and Prognosis of Lung Cancer |
| Q35053186 | Association between microRNA polymorphisms and cancer risk based on the findings of 66 case-control studies |
| Q38431557 | Association of single nucleotide polymorphisms in microRNAs with susceptibility to hepatitis B virus infection and HBV-related liver complications: A study in a Saudi Arabian population. |
| Q38712721 | Astaxanthin Inhibits PC-3 Xenograft Prostate Tumor Growth in Nude Mice |
| Q40202794 | BRMS1 gene expression may be associated with clinico-pathological features of breast cancer |
| Q37899447 | Basic research in kidney cancer |
| Q27004412 | Bioinformatic tools for microRNA dissection |
| Q36758011 | Biomarkers for Bone Tumours: Discovery from Genomics and Proteomics Studies and Their Challenges. |
| Q92731617 | Biomarkers for Stratification in Colorectal Cancer: MicroRNAs |
| Q30828773 | CAP-miRSeq: a comprehensive analysis pipeline for microRNA sequencing data |
| Q49409776 | COX-2 induces oncogenic micro RNA miR655 in human breast cancer |
| Q37141244 | Cerebrospinal fluid miRNA profile in HIV-encephalitis. |
| Q34375821 | Characterization of microRNA expression profiles in normal and osteoarthritic human chondrocytes. |
| Q35710995 | Circulating MicroRNAs as Minimally Invasive Biomarkers for Cancer Theragnosis and Prognosis |
| Q51854381 | Circulating biomarkers in renal cell carcinoma: the link between microRNAs and extracellular vesicles, where are we now? |
| Q54300178 | Circulating miRNA is a novel marker for head and neck squamous cell carcinoma. |
| Q35036105 | Circulating microRNAs: potential biomarkers for cancer |
| Q39112548 | Clinical significance of microRNA-148a in patients with early relapse of stage II stage and III colorectal cancer after curative resection |
| Q48113464 | Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR. |
| Q38684616 | Competing endogenous RNA: A novel posttranscriptional regulatory dimension associated with the progression of cancer |
| Q34140539 | Complexity of the microRNA repertoire revealed by next-generation sequencing |
| Q90651960 | Comprehensive Assessment of the Relationship Between MicroRNA-124 and the Prognostic Significance of Cancer |
| Q37794908 | Conquering cancer through discovery research |
| Q33921298 | Cross-mapping events in miRNAs reveal potential miRNA-mimics and evolutionary implications |
| Q27026846 | Current status of miRNA-targeting therapeutics and preclinical studies against gastroenterological carcinoma |
| Q34921140 | Decrease of miR-202-3p expression, a novel tumor suppressor, in gastric cancer |
| Q96304073 | Deep belief network-Based Matrix Factorization Model for MicroRNA-Disease Associations Prediction |
| Q36594081 | Defining Plasma MicroRNAs Associated With Cognitive Impairment In HIV-Infected Patients |
| Q33689752 | Deregulation of MicroRNAs in Gastric Lymphomagenesis Induced in the d3Tx Mouse Model of Helicobacter pylori Infection |
| Q40477162 | Deregulation of miR-93 and miR-143 in human esophageal cancer. |
| Q28655587 | Detection of circulating parasite-derived microRNAs in filarial infections |
| Q36850977 | Development of a deregulating microRNA panel for the detection of early relapse in postoperative colorectal cancer patients |
| Q33619253 | Diagnostic Value of Circulating Extracellular miR-134, miR-185, and miR-22 Levels in Lung Adenocarcinoma-Associated Malignant Pleural Effusion |
| Q38910308 | Differential Expression and Significance of Circulating microRNAs in Cerebrospinal Fluid of Acute Encephalitis Patients Infected with Japanese Encephalitis Virus. |
| Q21134708 | Differential expression of miRNAs in colorectal cancer: comparison of paired tumor tissue and adjacent normal mucosa using high-throughput sequencing |
| Q34796840 | Down-Regulated miR-30a in Clear Cell Renal Cell Carcinoma Correlated with Tumor Hematogenous Metastasis by Targeting Angiogenesis-Specific DLL4. |
| Q38977831 | Downregulation of PPP2R5E expression by miR-23a suppresses apoptosis to facilitate the growth of gastric cancer cells |
| Q54274193 | Downregulation of cell-free miR-198 as a diagnostic biomarker for lung adenocarcinoma-associated malignant pleural effusion. |
| Q39074816 | Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly |
| Q36656142 | Downregulation of miR-17~92 Expression Increase Paclitaxel Sensitivity in Human Ovarian Carcinoma SKOV3-TR30 Cells via BIM Instead of PTEN |
| Q36365499 | Downregulation of microRNA-132 by DNA hypermethylation is associated with cell invasion in colorectal cancer |
| Q39633529 | Dysregulation of microRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells |
| Q26798147 | Emerging Roles of MicroRNAs in EGFR-Targeted Therapies for Lung Cancer |
| Q38961844 | Enterococcus faecalis Infection and Reactive Oxygen Species Down-Regulates the miR-17-92 Cluster in Gastric Adenocarcinoma Cell Culture |
| Q36320751 | Evaluation and Adaptation of a Laboratory-Based cDNA Library Preparation Protocol for Retrospective Sequencing of Archived MicroRNAs from up to 35-Year-Old Clinical FFPE Specimens |
| Q30446145 | Evaluation of lung flute in sputum samples for molecular analysis of lung cancer |
| Q37695253 | Future directions for the early detection of colorectal cancer recurrence |
| Q38902049 | Gap Junctions Enhance the Antiproliferative Effect of MicroRNA-124-3p in Glioblastoma Cells |
| Q35731144 | Genetic variant rs16430 6bp > 0bp at the microRNA-binding site in TYMS and risk of sporadic breast cancer risk in non-Hispanic white women aged ≤ 55 years |
| Q40737717 | Grand Challenges and Opportunities in Deciphering the Role of Non-Coding RNAs in Human Diseases |
| Q37109882 | High blood sugar levels significantly impact the prognosis of colorectal cancer patients through down-regulation of microRNA-16 by targeting Myb and VEGFR2. |
| Q33596719 | High-throughput miRNA profiling of human melanoma blood samples |
| Q33762682 | Hsa-miR-574-5p negatively regulates MACC-1 expression to suppress colorectal cancer liver metastasis |
| Q92615593 | Hydrogel-Coated Microneedle Arrays for Minimally Invasive Sampling and Sensing of Specific Circulating Nucleic Acids from Skin Interstitial Fluid |
| Q90682237 | Hypoxia Activates SOX5/Wnt/β-Catenin Signaling by Suppressing MiR-338-3p in Gastric Cancer |
| Q38688935 | Identification of microRNA 885-5p as a novel regulator of tumor metastasis by targeting CPEB2 in colorectal cancer |
| Q34141549 | Identification of suitable reference genes for the relative quantification of microRNAs in pleural effusion |
| Q27016123 | Impact of Nutrition on Non-Coding RNA Epigenetics in Breast and Gynecological Cancer |
| Q39001625 | Influence of peripheral whole-blood microRNA-7 and microRNA-221 high expression levels on the acquisition of castration-resistant prostate cancer: evidences from in vitro and in vivo studies. |
| Q38616907 | Inhibition of MicroRNA miR-222 with LNA Inhibitor Can Reduce Cell Proliferation in B Chronic Lymphoblastic Leukemia |
| Q55000717 | Integrated analysis of colorectal cancer microRNA datasets: identification of microRNAs associated with tumor development. |
| Q61807715 | Integrating random walk and binary regression to identify novel miRNA-disease association |
| Q37611360 | Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer |
| Q38940586 | Involvement of Non-coding RNAs in the Signaling Pathways of Colorectal Cancer |
| Q48321863 | Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma |
| Q38800139 | Knockdown of microRNA-29a Changes the Expression of Heat Shock Proteins in Breast Carcinoma MCF-7 Cells. |
| Q49083521 | Let-7a suppresses glioma cell proliferation and invasion through TGF-β/Smad3 signaling pathway by targeting HMGA2. |
| Q39460937 | Let-7c functions as a metastasis suppressor by targeting MMP11 and PBX3 in colorectal cancer. |
| Q91783143 | LncRNA SNHG16 Promotes Hepatocellular Carcinoma Proliferation, Migration and Invasion by Regulating miR-186 Expression |
| Q101052511 | Long Noncoding RNA VPS9D1-AS1 Sequesters microRNA-525-5p to Promote the Oncogenicity of Colorectal Cancer Cells by Upregulating HMGA1 |
| Q47426600 | Long non-coding RNA SNHG1 regulates NOB1 expression by sponging miR-326 and promotes tumorigenesis in osteosarcoma |
| Q47168973 | Long noncoding RNA NEAT1 promotes nasopharyngeal carcinoma progression through regulation of miR-124/NF-κB pathway |
| Q51601680 | Loss of APAF-1 expression is associated with early recurrence in stage I, II, and III colorectal cancer. |
| Q47097674 | MKRMDA: multiple kernel learning-based Kronecker regularized least squares for MiRNA-disease association prediction |
| Q36963006 | Meta-analysis of the differentially expressed microRNA profiles in nasopharyngeal carcinoma |
| Q36913739 | Methylated DNA and microRNA in body fluids as biomarkers for cancer detection. |
| Q38721848 | MiR-124 down-regulation is critical for cancer associated fibroblasts-enhanced tumor growth of oral carcinoma |
| Q39061756 | MiR-17-92 cluster promotes hepatocarcinogenesis |
| Q47568135 | MiR-29a: a potential therapeutic target and promising biomarker in tumors |
| Q35781321 | MiR-34a suppresses amphiregulin and tumor metastatic potential of head and neck squamous cell carcinoma (HNSCC) |
| Q54112524 | MiR-422a regulates cellular metabolism and malignancy by targeting pyruvate dehydrogenase kinase 2 in gastric cancer. |
| Q35202716 | MiR-506 is down-regulated in clear cell renal cell carcinoma and inhibits cell growth and metastasis via targeting FLOT1 |
| Q33850052 | MiR-874 inhibits metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma by targeting SOX12 |
| Q39164512 | MiR199b suppresses expression of hypoxia-inducible factor 1α (HIF-1α) in prostate cancer cells |
| Q45942073 | MiRNA expression signature for potentially predicting the prognosis of ovarian serous carcinoma. |
| Q37982054 | MiRNAs and LincRNAs: Could they be considered as biomarkers in colorectal cancer? |
| Q40867466 | Micro-RNA (miRNA) profile in Hodgkin lymphoma: association between clinical and pathological variables |
| Q34191885 | MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer |
| Q50060667 | MicroRNA Expression Levels and Histopathological Features of Colorectal Cancer. |
| Q37978857 | MicroRNA alterations in Barrett's esophagus, esophageal adenocarcinoma, and esophageal adenocarcinoma cell lines following cranberry extract treatment: Insights for chemoprevention |
| Q37994747 | MicroRNA as a novel drug target for cancer therapy |
| Q27027738 | MicroRNA era: the importance for diagnosis and prognosis of adrenocortical tumors |
| Q33952288 | MicroRNA expression and clinical outcome of small cell lung cancer |
| Q92248266 | MicroRNA expression patterns in oral squamous cell carcinoma: hsa-mir-99b-3p and hsa-mir-100-5p as novel prognostic markers for oral cancer |
| Q42028379 | MicroRNA miR-125a-3p modulates molecular pathway of motility and migration in prostate cancer cells |
| Q34147511 | MicroRNA signatures in tumor tissue related to angiogenesis in non-small cell lung cancer |
| Q37745975 | MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9. |
| Q39064541 | MicroRNA-10b overexpression promotes non-small cell lung cancer cell proliferation and invasion |
| Q34382704 | MicroRNA-126 inhibits tumor cell growth and its expression level correlates with poor survival in non-small cell lung cancer patients |
| Q41894824 | MicroRNA-145 inhibits the proliferation, migration and invasion of the human TCA8113 oral cancer line |
| Q37170620 | MicroRNA-148b Acts as a Tumor Suppressor in Cervical Cancer by Inducing G1/S-Phase Cell Cycle Arrest and Apoptosis in a Caspase-3-Dependent Manner |
| Q55347861 | MicroRNA-154 functions as a tumor suppressor in non-small cell lung cancer through directly targeting B-cell-specific Moloney murine leukemia virus insertion site 1. |
| Q50878107 | MicroRNA-15b Suppresses Th17 Differentiation and Is Associated with Pathogenesis of Multiple Sclerosis by Targeting O-GlcNAc Transferase. |
| Q34031832 | MicroRNA-19a and -19b regulate cervical carcinoma cell proliferation and invasion by targeting CUL5. |
| Q35955257 | MicroRNA-212 suppresses tumor growth of human hepatocellular carcinoma by targeting FOXA1. |
| Q64989952 | MicroRNA-218 enhances gastric cancer cell cisplatin sensitivity by targeting survivin. |
| Q38712799 | MicroRNA-223 Promotes Tumor Progression in Lung Cancer A549 Cells via Activation of the NF-κB Signaling Pathway |
| Q53093014 | MicroRNA-23a expression in paraffin-embedded specimen correlates with overall survival of diffuse large B-cell lymphoma. |
| Q51430314 | MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma. |
| Q28116258 | MicroRNA-29a suppresses the growth, migration, and invasion of lung adenocarcinoma cells by targeting carcinoembryonic antigen-related cell adhesion molecule 6 |
| Q41615526 | MicroRNA-320 suppresses cervical cancer cell viability, migration and invasion via directly targeting FOXM1. |
| Q92652619 | MicroRNA-326 Functions as a Tumor Suppressor in Breast Cancer by Targeting ErbB/PI3K Signaling Pathway |
| Q52595053 | MicroRNA-337 regulates the PI3K/AKT and Wnt/β-catenin signaling pathways to inhibit hepatocellular carcinoma progression by targeting high-mobility group AT-hook 2. |
| Q38701714 | MicroRNA-33a promotes cell proliferation and inhibits apoptosis by targeting PPARα in human hepatocellular carcinoma |
| Q42835046 | MicroRNA-345 inhibits hepatocellular carcinoma metastasis by inhibiting YAP1. |
| Q21202162 | MicroRNA-34a modulates genes involved in cellular motility and oxidative phosphorylation in neural precursors derived from human umbilical cord mesenchymal stem cells |
| Q90429362 | MicroRNA-425 promotes the development of lung adenocarcinoma via targeting A disintegrin and metalloproteinases 9 (ADAM9) |
| Q36320426 | MicroRNA-519a promotes proliferation and inhibits apoptosis of hepatocellular carcinoma cells by targeting FOXF2. |
| Q91817278 | MicroRNA-520f-3p inhibits proliferation of gastric cancer cells via targeting SOX9 and thereby inactivating Wnt signaling |
| Q35093784 | MicroRNA-576-3p inhibits proliferation in bladder cancer cells by targeting cyclin D1. |
| Q38827376 | MicroRNA-608 acts as a prognostic marker and inhibits the cell proliferation in hepatocellular carcinoma by macrophage migration inhibitory factor |
| Q47135248 | MicroRNA-616 promotes the growth and metastasis of non-small cell lung cancer by targeting SOX7. |
| Q39455039 | MicroRNA-622 functions as a tumor suppressor by targeting K-Ras and enhancing the anticarcinogenic effect of resveratrol |
| Q35956839 | MicroRNA-638 inhibits cell proliferation by targeting phospholipase D1 in human gastric carcinoma |
| Q36640282 | MicroRNA-711 is a prognostic factor for poor overall survival and has an oncogenic role in breast cancer |
| Q90643159 | MicroRNA-877 is downregulated in cervical cancer and directly targets MACC1 to inhibit cell proliferation and invasion |
| Q36866382 | MicroRNA-92b promotes hepatocellular carcinoma progression by targeting Smad7 and is mediated by long non-coding RNA XIST. |
| Q26822743 | MicroRNA: a new and promising potential biomarker for diagnosis and prognosis of ovarian cancer |
| Q37828424 | MicroRNAs (miRNAs) in cancer invasion and metastasis: therapeutic approaches based on metastasis-related miRNAs |
| Q38088117 | MicroRNAs Involved in Anti-Tumour Immunity |
| Q26796592 | MicroRNAs and Growth Factors: An Alliance Propelling Tumor Progression |
| Q38064314 | MicroRNAs as diagnostic biomarkers in gastric cancer |
| Q38018097 | MicroRNAs as therapeutic targets and their potential applications in cancer therapy |
| Q28293733 | MicroRNAs as therapeutic targets for lung cancer |
| Q36727816 | MicroRNAs in common human diseases |
| Q37690810 | MicroRNAs: New Insight in Modulating Follicular Atresia: A Review |
| Q34947560 | Mir-55 inhibition can reduce cell proliferation and induce apoptosis in Jurkat (Acute T cell Leukemia) cell line |
| Q33906108 | Modeling microRNA-mRNA interactions using PLS regression in human colon cancer |
| Q49887992 | Molecular subtyping of nasopharyngeal carcinoma (NPC) and a microRNA-based prognostic model for distant metastasis. |
| Q39934018 | Multiple regression analysis of mRNA-miRNA associations in colorectal cancer pathway. |
| Q34332303 | Neural network cascade optimizes microRNA biomarker selection for nasopharyngeal cancer prognosis |
| Q34326351 | Non-random integration of the HPV genome in cervical cancer |
| Q35156742 | Novel candidate key drivers in the integrative network of genes, microRNAs, methylations, and copy number variations in squamous cell lung carcinoma. |
| Q47447137 | OncomiR: An online resource for exploring pan-cancer microRNA dysregulation |
| Q34499539 | Overexpression of miR-142-5p and miR-155 in gastric mucosa-associated lymphoid tissue (MALT) lymphoma resistant to Helicobacter pylori eradication |
| Q91729549 | Plasma microRNA: A novel non-invasive biomarker for HBV-associated liver fibrosis staging |
| Q38214481 | Point-of-care diagnostic tools to detect circulating microRNAS as biomarkers of disease |
| Q92553028 | Post-transcriptional regulation of Rad51c by miR-222 contributes cellular transformation |
| Q37643929 | Potential Value of miR-221/222 as Diagnostic, Prognostic, and Therapeutic Biomarkers for Diseases |
| Q38667456 | Prognostic and predictive miRNA biomarkers in bladder, kidney and prostate cancer: Where do we stand in biomarker development? |
| Q34264973 | Prognostic role of microRNA-21 in gastric cancer: a meta-analysis |
| Q30245349 | Prognostic significance of low microRNA-218 expression in patients with different types of cancer: Evidence from published studies |
| Q54235737 | Prognostic significance of miR-34a and its target proteins of FOXP1, p53, and BCL2 in gastric MALT lymphoma and DLBCL. |
| Q50947118 | Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. |
| Q87451279 | Quantitative assessment of the association between miR-196a2 rs11614913 polymorphism and cancer risk: evidence based on 45,816 subjects |
| Q36034189 | RBMMMDA: predicting multiple types of disease-microRNA associations |
| Q85033778 | Recent progress in genetic variants associated with cancer and their implications in diagnostics development |
| Q91876482 | Regulation of cytochrome P450 expression by microRNAs and long noncoding RNAs: Epigenetic mechanisms in environmental toxicology and carcinogenesis |
| Q38160090 | Renal cell carcinoma development and miRNAs: a possible link to the EGFR pathway. |
| Q88459288 | Research Progress on Rolling Circle Amplification (RCA)-Based Biomedical Sensing |
| Q88753994 | Retrospective MicroRNA Sequencing: Complementary DNA Library Preparation Protocol Using Formalin-fixed Paraffin-embedded RNA Specimens |
| Q38237787 | Role of microRNA-34 family in cancer with particular reference to cancer angiogenesis. |
| Q36585153 | Roles of microRNA on cancer cell metabolism |
| Q35628464 | Screening for characteristic microRNAs between pre-invasive and invasive stages of cervical cancer |
| Q53089445 | Serum microRNA expression profiling predict response to R-CHOP treatment in diffuse large B cell lymphoma patients. |
| Q26827171 | Significance and therapeutic value of miRNAs in embryonal neural tumors |
| Q54959229 | Single nucleotide polymorphism rs696 in miR449a binding site of NFKBIA gene is correlated with risk of colorectal cancer. |
| Q37457617 | Small RNAs and the competing endogenous RNA network in high grade serous ovarian cancer tumor spread |
| Q34160540 | Strategies to promote translational research within the European Organisation for Research and Treatment of Cancer (EORTC) Head and Neck Cancer Group: a report from the Translational Research Subcommittee |
| Q45902808 | Synthetic regulatory RNAs selectively suppress the progression of bladder cancer. |
| Q38710305 | The Potential of MicroRNAs as Prostate Cancer Biomarkers. |
| Q28079948 | The Potentials and Pitfalls of Microarrays in Neglected Tropical Diseases: A Focus on Human Filarial Infections |
| Q36388133 | The Roles of MicroRNA-122 Overexpression in Inhibiting Proliferation and Invasion and Stimulating Apoptosis of Human Cholangiocarcinoma Cells |
| Q92280511 | The Roles of miRNAs in Medulloblastoma: A Systematic Review |
| Q41147530 | The association between four genetic variants in microRNAs (rs11614913, rs2910164, rs3746444, rs2292832) and cancer risk: evidence from published studies |
| Q35259498 | The characteristics of the porcine (Sus scrofa) liver miRNAome with the use of next generation sequencing. |
| Q37937462 | The dual role of sirtuins in cancer |
| Q34806020 | The functional significance of microRNA-29c in patients with colorectal cancer: a potential circulating biomarker for predicting early relapse. |
| Q38694530 | The miR-125a-3p Inhibits TIM-3 Expression in AML Cell Line HL-60 In Vitro |
| Q38164634 | The origin, function, and diagnostic potential of extracellular microRNAs in human body fluids |
| Q34177547 | The potential of microRNAs in personalized medicine against cancers |
| Q40928109 | The potential value of miR-1 and miR-374b as biomarkers for colorectal cancer |
| Q89311006 | The prognostic value of microRNA-183 in human cancers: A meta-analysis |
| Q35933934 | The prognostic value of the miR-200 family in ovarian cancer: a meta-analysis. |
| Q37996436 | The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies. |
| Q38239173 | Towards developing biomarkers for glioblastoma multiforme: a proteomics view |
| Q36668241 | Transcription factor CCAAT/enhancer binding protein alpha up-regulates microRNA let-7a-1 in lung cancer cells by direct binding |
| Q37727428 | Triptolide inhibits the proliferation of cells from lymphocytic leukemic cell lines in association with downregulation of NF-κB activity and miR-16-1*. |
| Q34531091 | Unique microRNA-profiles in EGFR-mutated lung adenocarcinomas |
| Q92255072 | Validation of miR-1228-3p as Housekeeping for MicroRNA Analysis in Liquid Biopsies from Colorectal Cancer Patients |
| Q38129463 | When less is more--microRNAs and psychiatric disorders. |
| Q87445094 | [Exploiting the therapeutic potential of microRNAs in human cancer] |
| Q82893669 | [MicroRNAs as therapeutic targets for lung cancer] |
| Q84867203 | [Molecular diagnostics for monitoring and predicting therapeutic effect in cancer] |
| Q64903072 | [Promises and challenges in developing MiRNA as a molecular diagnostic tool for lung cancer]. |
| Q64992147 | [Recent progress in genetic variants associated with cancer and their implications in diagnostics development]. |
| Q47093612 | miR-1 suppresses the proliferation and promotes the apoptosis of esophageal carcinoma cells by targeting Src. |
| Q35819563 | miR-122 negatively correlates with liver fibrosis as detected by histology and FibroScan |
| Q35677296 | miR-1228 promotes the proliferation and metastasis of hepatoma cells through a p53 forward feedback loop |
| Q34109826 | miR-129 as a novel therapeutic target and biomarker in gastrointestinal cancer |
| Q39156827 | miR-135a/b modulate cisplatin resistance of human lung cancer cell line by targeting MCL1. |
| Q34273176 | miR-143 and miR-145 synergistically regulate ERBB3 to suppress cell proliferation and invasion in breast cancer |
| Q39376552 | miR-192, miR-194, miR-215, miR-200c and miR-141 are downregulated and their common target ACVR2B is strongly expressed in renal childhood neoplasms |
| Q49378623 | miR-195 inhibits cell proliferation and angiogenesis in human prostate cancer by downregulating PRR11 expression |
| Q39030478 | miR-20a promotes prostate cancer invasion and migration through targeting ABL2. |
| Q38319595 | miR-214: a potential biomarker and therapeutic for different cancers |
| Q38989276 | miR-221/222 promotes S-phase entry and cellular migration in control of basal-like breast cancer. |
| Q51420219 | miR-296 inhibits proliferation and induces apoptosis by targeting FGFR1 in human hepatocellular carcinoma. |
| Q45344075 | miR-29a-3p suppresses cell proliferation and migration by downregulating IGF1R in hepatocellular carcinoma |
| Q91340165 | miR-301a expression: Diagnostic and prognostic marker for prostate cancer |
| Q36209039 | miR-491 regulates glioma cells proliferation by targeting TRIM28 in vitro |
| Q89474962 | miR-548x and miR-4698 controlled cell proliferation by affecting the PI3K/AKT signaling pathway in Glioblastoma cell lines |
| Q37229470 | miR-99 inhibits cervical carcinoma cell proliferation by targeting TRIB2 |
| Q38881549 | miRNAs: mediators of ErbB family targeted therapy resistance |
| Q50300870 | miRToolsGallery: a tag-based and rankable microRNA bioinformatics resources database portal. |
| Q34163429 | microRNA levels in paraffin-embedded indolent B-cell non-Hodgkin lymphoma tissues from patients chronically infected with hepatitis B or C virus |
| Q36083620 | microRNA-10b Is Overexpressed and Critical for Cell Survival and Proliferation in Medulloblastoma |
| Q61626102 | microRNAs in the Malignant Transformation Process |
| Q52657236 | rs11614913 polymorphism in miRNA-196a2 and cancer risk: an updated meta-analysis. |
| Q38043064 | siRNA delivery: from lipids to cell-penetrating peptides and their mimics |